JP2009501001A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009501001A5 JP2009501001A5 JP2008514849A JP2008514849A JP2009501001A5 JP 2009501001 A5 JP2009501001 A5 JP 2009501001A5 JP 2008514849 A JP2008514849 A JP 2008514849A JP 2008514849 A JP2008514849 A JP 2008514849A JP 2009501001 A5 JP2009501001 A5 JP 2009501001A5
- Authority
- JP
- Japan
- Prior art keywords
- virus
- capsid fusion
- fusion peptide
- particle
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 64
- 210000000234 capsid Anatomy 0.000 claims 43
- 230000004927 fusion Effects 0.000 claims 42
- 230000003612 virological effect Effects 0.000 claims 30
- 239000002245 particle Substances 0.000 claims 28
- 230000000890 antigenic effect Effects 0.000 claims 22
- 241000700605 Viruses Species 0.000 claims 18
- 238000000034 method Methods 0.000 claims 16
- 150000007523 nucleic acids Chemical class 0.000 claims 10
- 108020004707 nucleic acids Proteins 0.000 claims 8
- 102000039446 nucleic acids Human genes 0.000 claims 8
- 238000000338 in vitro Methods 0.000 claims 5
- 208000015181 infectious disease Diseases 0.000 claims 5
- 230000002458 infectious effect Effects 0.000 claims 5
- 108091034117 Oligonucleotide Proteins 0.000 claims 4
- 230000003308 immunostimulating effect Effects 0.000 claims 4
- 241000724254 Cowpea chlorotic mottle virus Species 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 230000001717 pathogenic effect Effects 0.000 claims 3
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 241000589540 Pseudomonas fluorescens Species 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 230000000593 degrading effect Effects 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68654105P | 2005-06-01 | 2005-06-01 | |
| PCT/US2006/021262 WO2007053188A2 (en) | 2005-06-01 | 2006-06-01 | Production of multivalent virus like particles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009501001A JP2009501001A (ja) | 2009-01-15 |
| JP2009501001A5 true JP2009501001A5 (enExample) | 2009-07-09 |
Family
ID=38006346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008514849A Pending JP2009501001A (ja) | 2005-06-01 | 2006-06-01 | 多価ウイルス様粒子の製造 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20070041999A1 (enExample) |
| EP (1) | EP1885394A4 (enExample) |
| JP (1) | JP2009501001A (enExample) |
| KR (1) | KR20080018176A (enExample) |
| CN (1) | CN101287489A (enExample) |
| AU (1) | AU2006309286A1 (enExample) |
| BR (1) | BRPI0611336A2 (enExample) |
| CA (1) | CA2608515A1 (enExample) |
| WO (1) | WO2007053188A2 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100021391A1 (en) * | 2006-07-14 | 2010-01-28 | Montana State University | Novel nanoparticles for biofilm targeting |
| SG10202012986SA (en) | 2006-09-29 | 2021-01-28 | Ligocyte Pharmaceuticals Inc | Norovirus vaccine formulations |
| WO2009033004A1 (en) * | 2007-09-07 | 2009-03-12 | Montana State University | Protein cages and their uses |
| US20100266636A1 (en) | 2007-09-18 | 2010-10-21 | Ligocyte Pharmaceuticals, Inc. | Method of conferring a protective immune response to norovirus |
| CN101918028B (zh) | 2007-09-18 | 2015-01-07 | 莱戈赛特医药股份有限公司 | 赋予针对诺如病毒的保护性免疫应答的疫苗 |
| CN102215861B (zh) * | 2009-06-19 | 2014-10-08 | 艾金株式会社 | 宫颈癌疫苗 |
| CN103154242B (zh) | 2010-07-06 | 2015-09-30 | 诺华股份有限公司 | 诺如病毒衍生的免疫原性组合物和方法 |
| MX356586B (es) | 2011-07-11 | 2018-06-05 | Takeda Vaccines Inc | Formulaciones parenterales de vacunas contra los norovirus. |
| SG11201406996VA (en) * | 2012-05-11 | 2014-11-27 | Medicago Inc | Rotavirus-like particle production in plants |
| EP2870238A4 (en) | 2012-07-05 | 2016-03-09 | Ohio State Innovation Foundation | COMPOSITIONS AND METHODS RELATED TO VIRAL VACCINES |
| US10086062B2 (en) | 2012-07-05 | 2018-10-02 | Ohio State Innovation Foundation | Infectious pancreatic necrosis virus (IPNV) vaccine compositions |
| WO2015101666A1 (en) * | 2014-01-03 | 2015-07-09 | Fundación Biofísica Bizkaia | VLPs, METHODS FOR THEIR OBTENTION AND APPLICATIONS THEREOF |
| US9599606B2 (en) * | 2014-06-10 | 2017-03-21 | The Board Of Regents Of The University Of Texas System | ADP-ribose detection reagents |
| CN105018463A (zh) * | 2015-06-05 | 2015-11-04 | 北京百迈客生物科技有限公司 | 一种用于次生代谢物含量高的植物组织的dna提取方法 |
| KR101830792B1 (ko) * | 2016-01-27 | 2018-02-21 | 건국대학교 산학협력단 | 항균 펩타이드를 포함하는 불용성 융합단백질 및 이를 이용한 항균 펩타이드의 제조 방법 |
| CN108558990A (zh) * | 2018-01-05 | 2018-09-21 | 山东省科学院生态研究所 | 肿瘤靶向肽f3修饰的豇豆褪绿斑驳病毒样颗粒的构建、表达及其应用 |
| US20230038487A1 (en) * | 2019-11-25 | 2023-02-09 | The Regents Of The University Of California | Modified viral therapeutics and uses thereof |
| AU2021378792A1 (en) * | 2020-11-11 | 2023-05-04 | California Institute Of Technology | Multivalent carriers and related vaccine compositions |
| CN115747170B (zh) * | 2022-08-29 | 2023-08-04 | 四川大学 | 一种豇豆褪绿斑驳病毒-多肽复合物及其在骨质疏松治疗中的应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4511503A (en) * | 1982-12-22 | 1985-04-16 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
| GB9108386D0 (en) | 1991-04-19 | 1991-06-05 | Agricultural Genetics Co | Modified plant viruses as vectors |
| GB9414118D0 (en) * | 1994-07-13 | 1994-08-31 | Axis Genetics Ltd | Modified plant viruses as vectors of heterologous peptides |
| US6042832A (en) * | 1996-08-28 | 2000-03-28 | Thomas Jefferson University | Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid proteins |
| EP1015561B1 (en) * | 1997-09-05 | 2006-07-19 | Medimmune, Inc. | In vitro method for disassembly/reassembly of papillomavirus virus-like particles (vlps) |
| US6171591B1 (en) * | 1997-12-08 | 2001-01-09 | Pentamer Pharmaceuticals, Inc. | Recombinant nodavirus compositions and methods |
| KR100312456B1 (ko) * | 1999-03-13 | 2001-11-03 | 윤덕용 | 슈도모나스 플루오레슨스 유래의 외래단백질 분비촉진유전자 |
| US6514948B1 (en) * | 1999-07-02 | 2003-02-04 | The Regents Of The University Of California | Method for enhancing an immune response |
| US7135282B1 (en) * | 1999-10-14 | 2006-11-14 | The Dow Chemical Company | Viral particles with exogenous internal epitopes |
| GB9924352D0 (en) * | 1999-10-14 | 1999-12-15 | Hellendoorn Koen | Methods,compositions and applications relating to the generation of novel plant viral particles |
| EP1253947A4 (en) * | 2000-01-31 | 2005-01-05 | Univ California | IMMUNOMODULATORY POLYNUCLEOTIDES FOR THE TREATMENT OF INFECTION BY AN INTRACELLULAR PATHOGEN |
| US20030050268A1 (en) * | 2001-03-29 | 2003-03-13 | Krieg Arthur M. | Immunostimulatory nucleic acid for treatment of non-allergic inflammatory diseases |
| AU2003217413A1 (en) * | 2002-02-14 | 2003-09-04 | Novavax, Inc. | Method for isolation and purification of expressed gene products in vitro |
| AU2003221704A1 (en) * | 2002-04-08 | 2003-10-27 | Siga Technologies, Inc. | Immunogenic peptides, and method of identifying same |
| JP2006507800A (ja) * | 2002-06-07 | 2006-03-09 | ラージ・スケール・バイオロジー・コーポレイション | 可撓性ワクチンアセンブリおよびワクチン送達プラットフォーム |
| WO2004004761A2 (en) | 2002-07-05 | 2004-01-15 | Denis Leclerc | Adjuvant viral particle |
| WO2005005614A2 (en) | 2003-07-03 | 2005-01-20 | Pecos Labs, Inc. | Combined b-cell and t-cell epitopes on vlp for improved vaccines |
| KR20060031607A (ko) * | 2003-07-10 | 2006-04-12 | 사이토스 바이오테크놀로지 아게 | 패킹된 바이러스-양 입자 |
| CN101151272A (zh) * | 2003-12-01 | 2008-03-26 | 陶氏环球技术公司 | 在假单胞菌中生产重组二十面体病毒样颗粒 |
-
2006
- 2006-06-01 KR KR1020077028015A patent/KR20080018176A/ko not_active Withdrawn
- 2006-06-01 JP JP2008514849A patent/JP2009501001A/ja active Pending
- 2006-06-01 BR BRPI0611336-2A patent/BRPI0611336A2/pt not_active IP Right Cessation
- 2006-06-01 CA CA002608515A patent/CA2608515A1/en not_active Abandoned
- 2006-06-01 CN CNA2006800196237A patent/CN101287489A/zh active Pending
- 2006-06-01 US US11/444,827 patent/US20070041999A1/en not_active Abandoned
- 2006-06-01 AU AU2006309286A patent/AU2006309286A1/en not_active Abandoned
- 2006-06-01 EP EP06844120A patent/EP1885394A4/en not_active Withdrawn
- 2006-06-01 WO PCT/US2006/021262 patent/WO2007053188A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009501001A5 (enExample) | ||
| Kanekiyo et al. | New vaccine design and delivery technologies | |
| Yan et al. | The application of virus-like particles as vaccines and biological vehicles | |
| Pushko et al. | Development of virus-like particle technology from small highly symmetric to large complex virus-like particle structures | |
| Xiao et al. | Large-scale production of foot-and-mouth disease virus (serotype Asia1) VLP vaccine in Escherichia coli and protection potency evaluation in cattle | |
| TWI688652B (zh) | 作為對抗腸病毒感染之免疫原的病毒顆粒及其製造 | |
| Sarkar et al. | Virus like particles-A recent advancement in vaccine development | |
| Betenbaugh et al. | Nucleocapsid-and virus-like particles assemble in cells infected with recombinant baculoviruses or vaccinia viruses expressing the M and the S segments of Hantaan virus | |
| WO2005055957A3 (en) | Influenza immunogen and vaccine | |
| WO2008115199A3 (en) | Chimeric virus vaccines | |
| CA2405438A1 (en) | Hepatitis b core antigen fusion proteins | |
| JP2009516529A5 (enExample) | ||
| WO2007019247A3 (en) | Virus-like particles as vaccines for paramyxovirus | |
| JP2017515508A5 (enExample) | ||
| JP2006504644A5 (enExample) | ||
| WO2009014782A3 (en) | Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles | |
| CN104480143A (zh) | 一种表达脊髓灰质炎病毒样颗粒蛋白的载体及脊髓灰质炎病毒样颗粒的制备方法 | |
| CN104611358B (zh) | 一种在大肠杆菌中制备诺如病毒病毒样颗粒的方法 | |
| JP2025169275A5 (enExample) | ||
| CN108456663A (zh) | 一种1型牛病毒性腹泻病毒样颗粒及其制备与应用 | |
| JP2010508857A5 (enExample) | ||
| Rueda et al. | Influence of flanking sequences on presentation efficiency of a CD8+ cytotoxic T-cell epitope delivered by parvovirus-like particles | |
| JP2003514576A5 (enExample) | ||
| JP2009501012A5 (enExample) | ||
| MXPA02012593A (es) | Particulas de tipo virus del virus de la diarrea viral bovina. |